Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |